Hyderabad

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Bhagwan Mahavir Medical Research Centre, Hyderabad is organizing the National seminar on “Emerging trends, challenges and innovative approaches in Clinical Research in India” from 27th to 28th April, 2013 in connection with Mahavir Jayanthi.

The All India Council for Technical Education (AICTE) was established by an Act of Parliament (No. 52 of 1987) with a view to provide proper planning and coordinated development of the technical education system throughout the country, the promotion of qualitative improvements of such education in relation to planned quantitative growth and the regulation and proper maintenance of norms and standards in the technical education system and for matters connected therewith.

The Training and Development effort at Colgate-Palmolive is a direct outcome of the Individual Development Plan and the Business need. The business critical and individual specific needs are identified every year and a training needs inventory is drawn up.

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline.

The Indian Council of Medical Research (ICMR), New Delhi, the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world.

ABOUT AUTHOR:
Sunitha Manthena
Nalla Narsimha Reddy School of Pharmacy,
Narapally, Hyderabad
Affiliated to JNTU(H);
sunithatgk@gmail.com

INTRODUCTION
The expenses for developing new drugs are exorbitant. Thus in the present scenario, more emphasis is laid  to develop newer drug delivery technologies, which would ensure better patient compliance, drug efficacy and extends the term of patents of the existing molecules. In the present era, the pharmaceutical industry is facing several challenges due to worldwide competition and growing demand for better products.¹

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline.